The North America Bunion Correction Systems Market should witness market growth of 6.5% CAGR during the forecast period (2022-2028).
One important reason that is projected to drive the market growth is the availability of a wide range of different surgical and non-surgical procedures to manage the problem, such as PROstep MIS, a non-invasive process. In general, orthopedic implants, bunion pads and tapings, painkillers, injectables, surgery, injections, and physical therapy are used to treat bunions.
The market is predicted to rise with the increasing number of procedures aiming to treat the condition; for example, according to a San Mateo Podiatry Group article, approximately 150,000 surgeries are performed annually in the United States. Additionally, the FDA's continued approval of new products is anticipated to fuel market growth.
About one-third of adults in the United States suffer from bunions, which are a highly prevalent foot condition. Bunions are more common as people age. Because to differences in foot architecture, footwear, and hereditary variables, they are more prevalent in women than in males. Companies are expanding their offering of foot and ankle solutions in an effort to market the most recent items in the North American market.
The US market dominated the North America Bunion Correction Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $356.6 million by 2028. The Canada market is poised to grow at a CAGR of 9% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 8% during (2022-2028).
Based on Product, the market is segmented into Wearables and Implants & Accessories. Based on End-Use, the market is segmented into Hospitals, Ambulatory Centers, and Specialty Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings, Inc., Extremity Medical, LLC., Acumed, LLC., De Puy Synthes (Johnson & Johnson), BioPro, Inc., and Orthofix Medical, Inc.
One important reason that is projected to drive the market growth is the availability of a wide range of different surgical and non-surgical procedures to manage the problem, such as PROstep MIS, a non-invasive process. In general, orthopedic implants, bunion pads and tapings, painkillers, injectables, surgery, injections, and physical therapy are used to treat bunions.
The market is predicted to rise with the increasing number of procedures aiming to treat the condition; for example, according to a San Mateo Podiatry Group article, approximately 150,000 surgeries are performed annually in the United States. Additionally, the FDA's continued approval of new products is anticipated to fuel market growth.
About one-third of adults in the United States suffer from bunions, which are a highly prevalent foot condition. Bunions are more common as people age. Because to differences in foot architecture, footwear, and hereditary variables, they are more prevalent in women than in males. Companies are expanding their offering of foot and ankle solutions in an effort to market the most recent items in the North American market.
The US market dominated the North America Bunion Correction Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $356.6 million by 2028. The Canada market is poised to grow at a CAGR of 9% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 8% during (2022-2028).
Based on Product, the market is segmented into Wearables and Implants & Accessories. Based on End-Use, the market is segmented into Hospitals, Ambulatory Centers, and Specialty Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings, Inc., Extremity Medical, LLC., Acumed, LLC., De Puy Synthes (Johnson & Johnson), BioPro, Inc., and Orthofix Medical, Inc.
Scope of the Study
By Product
- Wearables
- Implants & Accessories
By End-use
- Hospitals
- Ambulatory Centers
- Specialty Centers
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Stryker Corporation
- Arthrex, Inc.
- Zimmer Biomet Holdings, Inc.
- Extremity Medical, LLC.
- Acumed, LLC.
- De Puy Synthes (Johnson & Johnson)
- BioPro, Inc.
- Orthofix Medical, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Bunion Correction Systems Market by Product
Chapter 5. North America Bunion Correction Systems Market by End-use
Chapter 6. North America Bunion Correction Systems Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Stryker Corporation
- Arthrex, Inc.
- Zimmer Biomet Holdings, Inc.
- Extremity Medical, LLC.
- Acumed, LLC.
- De Puy Synthes (Johnson & Johnson)
- BioPro, Inc.
- Orthofix Medical, Inc.
Methodology
LOADING...
